April 23, 2024, Guofa shares (600538Highestpayingcryptogamesandroid.sh) release the annual results report for 2023.
The company realized operating income of 369 million yuan, down 19.69% from the same period last year, and its net profit was-82 million yuan, from profit to loss compared with the same period last year. The net cash flow generated by operating activities was-18 million yuan, which continued to deteriorate over the same period last year, with an asset-liability ratio of 16.69%, an increase of 0.75% over the same period last year.
The company's gross profit margin on sales was 24.84%, down 3.05 percentage points from the same period last year, realizing basic earnings per share of-0.16 yuan, turning negative over the same period last year, and the rate of return on diluted net assets was-9.47%, turning negative over the same period last year.
The company's inventory turnover rate was 3.36 times, down 0.83 times from the same period last year, and the total asset turnover rate was 0.34 times, down 0.08 times from the same period last year.
The advance payment of the company is about 220000 yuan, the sales cost is about 36.74 million yuan, the management cost is about 53.97 million yuan, and the financial cost is about-3.06 million yuan.
The company is mainly engaged in wholesale business, DNA testing equipment and consumables, Pearl Mingmu eye drops, judicial expertise, pharmaceutical manufacturing.HighestpayingcryptogamesandroidOther products, ethanol disinfectant, DNA testing services, chain retail, other industries, and other businesses accounted for 26.70%, 36.34%, 18.51%, 7.15%, 3.29%, 1.70%, 3.37%, 3.02%, 1.34%,-1.42%. Revenue was 195 million yuan, 93.0708 million yuan, 22.3286 million yuan, 15.9589 million yuan, 13.8733 million yuan, 8.119 million yuan, 7.8563 million yuan, 6.8744 million yuan, 4.417 million yuan and 2.0905 million yuan respectively, with gross profit margins of 12.58%, 35.81%, 76.00%, 41.07%, 21.76%, 19.27%, 39.33%, 40.28%, 27.87% and-62.32%, respectively.
The number of shareholders is 30, 000, and the number of shares held by the top 10 shareholders is 188 million shares, accounting for 35.92% of the total equity. The top 10 shareholders are Zhu Rongjuan, Beihai Lugang Construction Investment and Development Co., Ltd., Peng Tao, Yao Fangyuan, Shengshi Rongbang (Guangzhou) Private Securities Investment Fund Management Co., Ltd.-Shengshi Rongbang 9 Securities Private Investment Fund, Guangzhou Jinghui Dantong Investment Management Co., Ltd. (limited partnership), Pan Libin, Shenzhen Zhongying Investment Management Co., Ltd.-Zhongying Sea Turtle Health No. 1 Private Equity Securities Investment Fund, Shengshi Rongbang (Guangzhou) Private Equity Investment Fund Management Co., Ltd.-Shengshi Rongbang No. 1 Securities Private Investment Fund, Guangdong Jinyang Private Equity Fund Management Co., Ltd.-Jinyang Arbitrage cta No. 1 Private Equity Investment Fund The shareholding ratio is 17.25%, 3.69%, 3.30%, 2.35%, 1.75%, 1.75%, 1.64%, 1.48%, 1.40% and 1.31%, respectively.
The total R & D expenditure of the company is 12.76 million yuan, and the proportion of R & D expenses in operating income is 3.46%, up 1.64% from the same period last year.
The above content has nothing to do with the data, has nothing to do with the position of the cloud channel in the interface, and does not constitute investment advice. Operate accordingly at your own risk.